Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Novel derivatives of 1,2,3-triazole, cannabinoid-1 receptor ligands modulate gastrointestinal motility in mice.

Szymaszkiewicz A, Zielinska M, Li K, Ramanathan M, Alam S, Hou DR, Fichna J, Storr M.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Feb 5. doi: 10.1007/s00210-018-1465-9. [Epub ahead of print]

PMID:
29404698
2.

Expanded Haemodialysis Therapy of Chronic Haemodialysis Patients Prevents Calcification and Apoptosis of Vascular Smooth Muscle Cells in vitro.

Willy K, Girndt M, Voelkl J, Fiedler R, Martus P, Storr M, Schindler R, Zickler D.

Blood Purif. 2017 Dec 22;45(1-3):131-138. doi: 10.1159/000484925. [Epub ahead of print]

PMID:
29402827
3.

Efficacy and safety of serotonin receptor ligands in the treatment of irritable bowel syndrome: a review.

Binienda A, Storr M, Fichna J, Salaga M.

Curr Drug Targets. 2017 Dec 27. doi: 10.2174/1389450119666171227225408. [Epub ahead of print]

PMID:
29284389
4.

FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue-derived hormone levels in mouse models mimicking constipation-predominant IBS.

Mosińska P, Jacenik D, Sałaga M, Wasilewski A, Cygankiewicz A, Sibaev A, Mokrowiecka A, Małecka-Panas E, Pintelon I, Storr M, Timmermans JP, Krajewska WM, Fichna J.

Neurogastroenterol Motil. 2017 Dec 20. doi: 10.1111/nmo.13272. [Epub ahead of print]

PMID:
29266569
5.

Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expression.

Zickler D, Luecht C, Willy K, Chen L, Witowski J, Girndt M, Fiedler R, Storr M, Kamhieh-Milz J, Schoon J, Geissler S, Ringdén O, Schindler R, Moll G, Dragun D, Catar R.

Nephrol Dial Transplant. 2017 Dec 8. doi: 10.1093/ndt/gfx316. [Epub ahead of print]

PMID:
29228352
6.

How do professional Australian Football League (AFL) players utilise social media during periods of injury? A mixed methods analysis.

Nankervis B, Ferguson L, Gosling C, Storr M, Ilic D, Young M, Maloney S.

J Sci Med Sport. 2017 Nov 7. pii: S1440-2440(17)31747-4. doi: 10.1016/j.jsams.2017.10.034. [Epub ahead of print]

PMID:
29174299
7.

[Four reasons for the bloated abdomen of your patient].

Storr M, Waggershauser C.

MMW Fortschr Med. 2017 Nov;159(20):43-48. doi: 10.1007/s15006-017-9601-x. German. No abstract available.

PMID:
29159608
8.

[Eosinophilic Esophagitis Update: New Guidelines of the European Study Group EUREOS].

Miehlke S, Schlag C, Storr M, Arnim UV.

Z Gastroenterol. 2018 Feb;56(2):139-150. doi: 10.1055/s-0043-121349. Epub 2017 Nov 9. German.

PMID:
29121691
9.

Modulation of leucocytic angiotensin-converting enzymes expression in patients maintained on high-permeable haemodialysis.

Trojanowicz B, Ulrich C, Fiedler R, Martus P, Storr M, Boehler T, Werner K, Hulko M, Zickler D, Willy K, Schindler R, Girndt M.

Nephrol Dial Transplant. 2018 Jan 1;33(1):34-43. doi: 10.1093/ndt/gfx206.

PMID:
28992224
10.

Membrane Innovation in Dialysis.

Boschetti-de-Fierro A, Beck W, Hildwein H, Krause B, Storr M, Zweigart C.

Contrib Nephrol. 2017;191:100-114. doi: 10.1159/000479259. Epub 2017 Sep 14.

11.

In vitro benchmark of cytokine removal by dialyzers with various permeability profiles.

Hulko M, Speidel R, Gauss J, Storr M, Krause B.

Int J Artif Organs. 2017 Oct 27;40(11):615-621. doi: 10.5301/ijao.5000639. Epub 2017 Aug 11.

PMID:
28862721
12.

Evaluating the Multitarget Effects of Combinations through Multistep Clustering of Pharmacological Data: the Example of the Commercial Preparation Iberogast.

Abdel-Aziz H, Kelber O, Lorkowski G, Storr M.

Planta Med. 2017 Oct;83(14-15):1130-1140. doi: 10.1055/s-0043-116852. Epub 2017 Aug 31. Review.

13.

Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles.

Latosinska A, Hulko M, Speidel R, Mischak H, Storr M, Krause B.

Artif Organs. 2018 Jan;42(1):78-87. doi: 10.1111/aor.12952. Epub 2017 Jul 26.

PMID:
28744941
14.

Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice.

Salaga M, Zatorski H, Zielińska M, Mosinska P, Timmermans JP, Kordek R, Storr M, Fichna J.

Naunyn Schmiedebergs Arch Pharmacol. 2017 Oct;390(10):1015-1027. doi: 10.1007/s00210-017-1402-3. Epub 2017 Jul 14.

PMID:
28710683
15.

Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT).

Bashashati M, Fichna J, Piscitelli F, Capasso R, Izzo AA, Sibaev A, Timmermans JP, Cenac N, Vergnolle N, Di Marzo V, Storr M.

Neurogastroenterol Motil. 2017 Dec;29(12). doi: 10.1111/nmo.13148. Epub 2017 Jul 11.

PMID:
28695708
16.

Medium cut-off membranes - closer to the natural kidney removal function.

Zweigart C, Boschetti-de-Fierro A, Hulko M, Nilsson LG, Beck W, Storr M, Krause B.

Int J Artif Organs. 2017 Jul 5;40(7):328-334. doi: 10.5301/ijao.5000603. Epub 2017 May 26. No abstract available.

17.

Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal.

Fabisiak A, Włodarczyk J, Fabisiak N, Storr M, Fichna J.

J Neurogastroenterol Motil. 2017 Jul 30;23(3):341-348. doi: 10.5056/jnm16203. Review.

18.

In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.

Willy K, Hulko M, Storr M, Speidel R, Gauss J, Schindler R, Zickler D.

Artif Organs. 2017 Sep;41(9):803-809. doi: 10.1111/aor.12884. Epub 2017 May 19.

PMID:
28524237
19.

Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C, Amil Dias J, Bove M, González-Cervera J, Larsson H, Miehlke S, Papadopoulou A, Rodríguez-Sánchez J, Ravelli A, Ronkainen J, Santander C, Schoepfer AM, Storr MA, Terreehorst I, Straumann A, Attwood SE.

United European Gastroenterol J. 2017 Apr;5(3):335-358. doi: 10.1177/2050640616689525. Epub 2017 Jan 23. Review.

20.

Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.

Madisch A, Vinson BR, Abdel-Aziz H, Kelber O, Nieber K, Kraft K, Storr M.

Wien Med Wochenschr. 2017 May;167(7-8):160-168. doi: 10.1007/s10354-017-0557-3. Epub 2017 Apr 19.

21.

[Current treatment of dyspepsia in primary care].

Waggershauser CH, Allescher HD, Storr M.

MMW Fortschr Med. 2017 Apr;159(7):46-54. doi: 10.1007/s15006-017-9044-4. German. No abstract available.

PMID:
28417420
22.

Remote-online case-based learning: A comparison of remote-online and face-to-face, case-based learning - a randomized controlled trial.

Nicklen P, Keating JL, Paynter S, Storr M, Maloney S.

Educ Health (Abingdon). 2016 Sep-Dec;29(3):195-202. doi: 10.4103/1357-6283.204213.

23.

Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome.

Wasilewski A, Lewandowska U, Mosinska P, Watala C, Storr M, Fichna J, Venkatesan T.

Am J Gastroenterol. 2017 Jun;112(6):933-939. doi: 10.1038/ajg.2017.73. Epub 2017 Mar 28.

PMID:
28349993
24.

Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?

Hasenoehrl C, Storr M, Schicho R.

Expert Rev Gastroenterol Hepatol. 2017 Apr;11(4):329-337. doi: 10.1080/17474124.2017.1292851. Epub 2017 Feb 16. Review.

25.

Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.

Mosińska P, Zatorski H, Storr M, Fichna J.

J Neurogastroenterol Motil. 2017 Apr 30;23(2):171-179. doi: 10.5056/jnm16183. Review.

26.

G protein-coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain.

Zielińska M, Fichna J, Bashashati M, Habibi S, Sibaev A, Timmermans JP, Storr M.

Neurogastroenterol Motil. 2017 Jul;29(7). doi: 10.1111/nmo.13025. Epub 2017 Feb 12.

PMID:
28191706
27.

Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.

Taschler U, Hasenoehrl C, Storr M, Schicho R.

Handb Exp Pharmacol. 2017;239:343-362. doi: 10.1007/164_2016_105. Review.

PMID:
28161834
28.

Detection of Free Advanced Glycation End Products in Vivo during Hemodialysis.

Hohmann C, Liehr K, Henning C, Fiedler R, Girndt M, Gebert M, Hulko M, Storr M, Glomb MA.

J Agric Food Chem. 2017 Feb 1;65(4):930-937. doi: 10.1021/acs.jafc.6b05013. Epub 2017 Jan 23.

PMID:
28112514
29.

Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial.

Zickler D, Schindler R, Willy K, Martus P, Pawlak M, Storr M, Hulko M, Boehler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Fiedler R, Girndt M.

PLoS One. 2017 Jan 13;12(1):e0169024. doi: 10.1371/journal.pone.0169024. eCollection 2017.

30.

Pain duration is associated with increased muscle sympathetic nerve activity in patients with Achilles tendinopathy.

Jewson JL, Lambert EA, Docking S, Storr M, Lambert GW, Gaida JE.

Scand J Med Sci Sports. 2017 Dec;27(12):1942-1949. doi: 10.1111/sms.12820. Epub 2016 Dec 28.

PMID:
28028840
31.

High cut-off hemofiltration versus standard hemofiltration: effect on plasma cytokines.

Atan R, Peck L, Visvanathan K, Skinner N, Eastwood G, Bellomo R, Storr M, Goehl H.

Int J Artif Organs. 2016 Nov 11;39(9):479-486. doi: 10.5301/ijao.5000527. Epub 2016 Nov 10.

PMID:
27834446
32.

Impact of serum and dialysates obtained from chronic hemodialysis patients maintained on high cut-off membranes on inflammation profile in human THP-1 monocytes.

Trojanowicz B, Ulrich C, Fiedler R, Storr M, Boehler T, Martus P, Pawlak M, Glomb MA, Henning C, Templin M, Werner K, Zickler D, Willy K, Schindler R, Girndt M.

Hemodial Int. 2017 Jul;21(3):348-358. doi: 10.1111/hdi.12494. Epub 2016 Sep 26.

PMID:
27670395
33.

Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile Infection.

Hagel S, Fischer A, Ehlermann P, Frank T, Tueffers K, Sturm A, Link A, Demir M, Siebenhaar A, Storr M, Glueck T, Siegel E, Solbach P, Goeser F, Koelbel CB, Lohse A, Luebbert C, Kandzi U, Maier M, Schuerle S, Lerch MM, Tacke D, Cornely OA, Stallmach A, Vehreschild M; German Clinical Microbiome Study Group (GCMSG).

Dtsch Arztebl Int. 2016 Sep 5;113(35-36):583-9. doi: 10.3238/arztebl.2016.0583.

34.

The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.

Hasenoehrl C, Taschler U, Storr M, Schicho R.

Neurogastroenterol Motil. 2016 Dec;28(12):1765-1780. doi: 10.1111/nmo.12931. Epub 2016 Aug 26. Review.

35.

Review: The Role of MOP and DOP Receptors in Treatment of Diarrheapredominant Irritable Bowel Syndrome.

Jarmuż A, Zielińska M, Leń K, Banaszek M, Storr M, Fichna J.

Mini Rev Med Chem. 2016;16(18):1462-1469. Review.

PMID:
27494159
36.

High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity.

Zickler D, Willy K, Girndt M, Fiedler R, Martus P, Storr M, Schindler R.

Nephrol Dial Transplant. 2016 Oct;31(10):1706-12. doi: 10.1093/ndt/gfw293. Epub 2016 Jul 20.

PMID:
27445317
37.

Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment.

Krohn RM, Parsons SA, Fichna J, Patel KD, Yates RM, Sharkey KA, Storr MA.

J Inflamm (Lond). 2016 Jul 14;13:21. doi: 10.1186/s12950-016-0129-0. eCollection 2016.

38.

[Halitosis and bad breath].

Waggershauser CH, Storr M.

MMW Fortschr Med. 2016 Jun 23;158(12):43-6. doi: 10.1007/s15006-016-8444-1. Review. German. No abstract available.

PMID:
27324003
39.

Effects of head flexion posture on the multidirectional static force capacity of the neck.

Gilchrist I, Moglo K, Storr M, Pelland L.

Clin Biomech (Bristol, Avon). 2016 Aug;37:44-52. doi: 10.1016/j.clinbiomech.2016.05.016. Epub 2016 Jun 2.

PMID:
27289496
40.

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome.

Sobolewska-Włodarczyk A, Włodarczyk M, Storr M, Fichna J.

Ther Clin Risk Manag. 2016 May 13;12:771-5. doi: 10.2147/TCRM.S83722. eCollection 2016. Review.

41.

[Lower gastrointestinal bleeding].

Waggershauser CH, Storr M.

MMW Fortschr Med. 2016 May 12;158(9):50-1. doi: 10.1007/s15006-016-8208-y. Review. German. No abstract available.

PMID:
27155708
42.

Mit Kaffeegenuss Gallensteine vermeiden.

Storr M.

MMW Fortschr Med. 2016 Mar 3;158(4):40. doi: 10.1007/s15006-016-7873-1. German. No abstract available.

PMID:
27119881
43.

[Healthy microbiome - healthy person?].

Storr M.

MMW Fortschr Med. 2016 Feb 18;158(3):42. doi: 10.1007/s15006-016-7817-9. German. No abstract available.

PMID:
27119695
44.

[Gluten sensitivity is real].

Storr M.

MMW Fortschr Med. 2016 Feb 18;158(3):38. doi: 10.1007/s15006-016-7809-9. German. No abstract available.

PMID:
27119689
45.

Registration factors that limit international mobility of people holding physiotherapy qualifications: A systematic review.

Foo JS, Storr M, Maloney S.

Health Policy. 2016 Jun;120(6):665-73. doi: 10.1016/j.healthpol.2016.04.008. Epub 2016 Apr 20. Review.

PMID:
27114105
46.

Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice.

Mosińska P, Socała K, Nieoczym D, Laudon M, Storr M, Fichna J, Wlaź P.

Behav Brain Res. 2016 Jul 1;307:199-207. doi: 10.1016/j.bbr.2016.03.036. Epub 2016 Mar 22.

PMID:
27016427
47.

[Larazotide as an option in case of failure of a gluten-free diet].

Storr M.

Med Monatsschr Pharm. 2016 Feb;39(2):89-90. German. No abstract available.

PMID:
26983338
48.

[A new remedy for diarrheal irritable bowel syndrome].

Storr M.

MMW Fortschr Med. 2016 Mar 17;158(5):43. doi: 10.1007/s15006-016-7937-2. German. No abstract available.

PMID:
26979218
49.

[Emergency checklist: Upper gastrointestinal bleeding].

Kubisch CH, Storr M.

MMW Fortschr Med. 2015 Nov 19;157(20):54, 56. German. No abstract available.

PMID:
26977518
50.

[Clostridium difficile are on the rise].

Storr M.

MMW Fortschr Med. 2015 Nov 12;157 Spec No 2:49. German. No abstract available.

PMID:
26953476

Supplemental Content

Support Center